ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 6 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,349,000 | -53.7% | 12,254,080 | 0.0% | 0.01% | -59.1% |
| Q2 2020 | $2,915,000 | +25.4% | 12,254,080 | 0.0% | 0.02% | 0.0% |
| Q1 2020 | $2,325,000 | -41.8% | 12,254,080 | +1.5% | 0.02% | -29.0% |
| Q4 2019 | $3,996,000 | -11.0% | 12,073,080 | 0.0% | 0.03% | -20.5% |
| Q3 2019 | $4,489,000 | +61.6% | 12,073,080 | 0.0% | 0.04% | +50.0% |
| Q2 2019 | $2,778,000 | -34.3% | 12,073,080 | 0.0% | 0.03% | -35.0% |
| Q1 2019 | $4,226,000 | -71.5% | 12,073,080 | 0.0% | 0.04% | -75.6% |
| Q4 2018 | $14,850,000 | -34.3% | 12,073,080 | -0.0% | 0.16% | -24.1% |
| Q3 2018 | $22,588,000 | -16.9% | 12,079,080 | 0.0% | 0.22% | -24.7% |
| Q2 2018 | $27,178,000 | +6250.0% | 12,079,080 | +6107.1% | 0.29% | +5640.0% |
| Q1 2018 | $428,000 | +11.2% | 194,600 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $385,000 | – | 194,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clear Creek Financial Management, LLC | 400,000 | $95,000 | 0.02% |
| Cambridge Investment Research Advisors, Inc. | 12,254,080 | $2,915,000 | 0.02% |
| jvl associates llc | 58,500 | $14,000 | 0.02% |
| RETIREMENT INCOME SOLUTIONS, INC | 32,060 | $7,000,000 | 0.00% |
| REILLY FINANCIAL ADVISORS, LLC | 59,600 | $14,000 | 0.00% |
| Ranch Capital Advisors Inc. | 10,000 | $1,000 | 0.00% |
| UBS Group AG | 54,974 | $13,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 225 | $54,000 | 0.00% |
| Krilogy Financial LLC | 10,000 | $2,000 | 0.00% |